BIR Annual Congress 2020

4th - 6th November 2020   (GMT+00:00) GMT

Up to 18 CPD credits available

With a record number of delegates last year, The BIR Annual Congress continues to get even BIGGER and BETTER in 2020! 

With the current situation and keeping in line with government guidelines, this year's Congress will be delivered virtually with an exciting new structure.

A mix of four different streams offering a comprehensive programme on the latest innovations in imaging and treatment to medical imaging professionals and their senior management teams.

Taking place over three days with a range of short pre-Congress sessions leading to the main days, the event provides excellent opportunities to learn, interact and engage with attendees, speakers and industry representatives. There will also be plenty of opportunities to ask questions.
 

This year's streams include:

  • Leadership and wellbeing
  • Artificial intelligence
  • Oncology
  • Patient protection
including exciting and insightful key note sessions by Dr Clare Gerada and Professor Evis Sala.

View provisional programme here


Who should attend?

Anyone with an interest and passion for radiology, radiation oncology and the underlying sciences, including radiologists, physicists, radiographers, oncologists, physicians, radiation protection advisers and supervisors.

Call for abstracts

The BIR Annual Congress programme organisers welcomes your abstracts for ePoster presentations relating to all areas of medical imaging and radiotherapy including educational case reports, audits and research.
 
If your abstract is accepted, you will be invited to upload and share your ePoster on our dedicated ePoster webpage as well as BIR Sharing Platform. Your ePoster will be available as an online resource for people to view your work before, during and after the event.
 
Please ensure that you have read the abstract submission guidelines. Abstracts submitted after the deadline will not be accepted.

Please note: We will only accept one abstract submission per presenting author per event. If you wish to submit any further abstracts, these will only be considered if you are a co-author and the presenting author is registered for the event.

Submit online here by: 5pm Friday 28 August 2020

Sponsorship opportunities

The BIR Annual Congress 2020 offers sponsors an excellent opportunity to reach out to a large number of multidisciplinary medical professionals - both national and international. Please view the virtual BIRAC20 sponsorship brochure to see the packages available.
 

To secure sponsorship at the congress, please complete and return the booking form to: conference@bir.org.uk

Registration fees* (Early bird)**
All BIR members: FREE
Non-member (Consultant or equivalent): £90
Non-member (Other grades): £55
Non-member (Student/Retired): £40

Registration fees*:
All BIR members: FREE
Non-member (Consultant or equivalent): £100
Non-member (Other grades): £65
Non-member (Student/Retired): £50

*VAT will be added at checkout
** Early bird expires on Sunday 4 October 2020

Venue

Speakers

Sponsors

We are very grateful to the following organisations for supporting this event.

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Resonance health

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit www.healthcare.siemens.co.uk